Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of ETD-001 gel for hypertrophic scars
CTR20264065Phase 2Active
- Sponsor
- ETOP Bio
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ETD-001 in Hypertrophic Scar (HS), sponsored by ETOP Bio. Started Nov 2026; status: active.
02
Drugs
ETD-001
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on CTR20264065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20264065.